Navigation Links
FDA Approves New Roche West Nile Virus Blood Screening Test
Date:9/3/2007

Automated test helps ensure safety of blood supply by detecting virus

earlier in infection cycle.

PLEASANTON, Calif., Aug. 28 /PRNewswire/ -- Roche Diagnostics announced that the US Food & Drug Administration (FDA) today approved its biologics license application for the company's test for direct detection of West Nile Virus in donated human blood and plasma. West Nile virus, which can cause serious health issues, is transmitted to humans most often through mosquito bites, but can also less commonly be transmitted by transfusion of infected blood or blood products. The test, called the cobas TaqScreen West Nile Virus Test, enables detection of the virus earlier in the infection cycle in donors who may show no symptoms of disease. According to the CDC, blood screening centers across the United States identified 340 donors whose blood tested positive for West Nile Virus in 2006 and 23 to date in 2007.

"We are pleased to offer US blood banks a new choice for both maximizing blood safety and optimizing efficiency," said Daniel O'Day, Head of Roche Molecular Diagnostics, the business area of Roche Diagnostics which developed the test. "The Roche test, run under an investigational new drug application by 14 clinical trial sites testing blood from a network of more than a 100 donation centers, helps blood banks streamline workflow and improve test results accuracy with reduced hands-on time, ready-to-use reagents, and full automation of each step."

The test is designed to run on the cobas s 201 system, Roche's flexible, modular instrument platform which automates each step of the real-time PCR blood screening process. The test uses Roche's highly sensitive polymerase chain reaction technology (PCR), the world's leading nucleic acid amplification technology, to detect the genetic material of the West Nile virus directly in blood. The United States Centers for Disease Control (CDC) has stated that screening donated blood for
'/>"/>

SOURCE Roche Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Approves Contraceptive Ring
2. FDA approves new device to treat womens bleeding disorder
3. FDA Approves New HIV Drug, Viread
4. FDA Approves Birth Control Skin Patch
5. FDA approves surgical gel
6. FDA Approves New Arthritis Drug, Bextra
7. FDA Approves Elidel Cream for Eczema
8. FDA approves drug for rare liver disease
9. FDA approves first pocket-sized EKG machine
10. FDA Approves New Anti-Clotting Drug
11. FDA Approves New surgery Treatment for Farsightedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... THURSDAY, July 31, 2014 (HealthDay News) -- A new report ... made to their doctor,s office involved diabetes, with the greatest ... the U.S. Centers for Disease Control and Prevention found the ... age group jumped by 34 percent between 2005 and 2010. ... and managing the blood sugar disease costs almost $245 billion ...
(Date:7/31/2014)... Kansas City, MO (PRWEB) July 31, 2014 ... recently recognized with an Excellence Through Insight award for ... Healthcare Providers and Systems (CG-CAHPS) database in multiple categories ... honor for their commitment to excellence in patient care. ... must have been a patient satisfaction-tracking client of HealthStream ...
(Date:7/31/2014)... 2014 With the brand change comes more ... lecture series featuring the “reality model” used by Franklin ... more affordable resort pricing structure, and a renewed focus on ... have always had a great weight loss program, we really ... Ridge. We want to change the way people feel about ...
(Date:7/31/2014)... previously linked to cognitive impairment in older adults ... according to investigators from the Regenstrief Institute, ... University of East Anglia and several other United ... more than a decade of studies on the ... that these drugs have a significant adverse effect ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 RankingBySEO, a ... for those individuals and organizations against whom negative reviews ... ‘Remove Negative Comments Service’. , About the service, ... have officially announced the service now, but we have ... of negative comments for several years.” , On being ...
Breaking Medicine News(10 mins):Health News:Big Jump in Doctor's Office Visits for Young Adults With Diabetes 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 3Health News:Weight Loss Destination, the Biggest Loser Resort in Utah, Rebrands as Fitness Ridge 2Health News:Common drugs adversely impair older adults' physical as well as cognitive functioning 2Health News:RankingBySEO Launches a New Service ‘Remove Negative Comments’ 2
... 24 (HealthDay News) -- Morbidly obese patients who undergo spinal ... and also face higher hospital costs, a new study says. ... spinal pain. People with a body mass index (BMI) of ... generally 50 to 100 percent over their ideal body weight, ...
... , WEDNESDAY, May 23 (HealthDay News) -- The risk of ... travel more slowly through the lower chambers of the heart, ... heart and cause it to pump blood through its four ... be measured using an electrocardiogram (ECG). The waves traveling through ...
... the most comprehensive analyses to date of the cost of ... that this now-dominant surgical approach is significantly more costly than ... patient outcomes. The results of the study are available online ... Urology . In one of the first ...
... that maintain healthy nerve connections as we age help keep ... charity Age UK has found. Older people with robust ... different, distant brain areas can process information quickly and ... According to the findings, joining distant parts of the ...
... , WEDNESDAY, May 23 (HealthDay News) -- The ... reduced through a multi-pronged approach that includes more training ... to a new German study. Despite legal regulations ... as bed rails and belts still are frequently used ...
... Minn. -- Mayo Clinic researchers will present findings on ... at the annual meeting of the American Urological Association ... be available to provide expert comment for reporters covering ... presented and their embargo dates include: No ...
Cached Medicine News:Health News:Severely Obese Have More Complications With Spinal Surgery 2Health News:Study Spots Early Warning Signal for Sudden Cardiac Death 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:Well-connected brains make you smarter in older age 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4
(Date:7/31/2014)... CHESTERBROOK, Pa. , July 31, 2014 /PRNewswire/ ... AUXL ), a specialty biopharmaceutical company, today ... million regulatory milestone payment from its partner Asahi ... due because of the successful submission of a ... Device Agency (PMDA) for XIAFLEX ® (collagenase ...
(Date:7/31/2014)... , 31 juli 2014 De Pfizer Clinical ... rekruteringscampagne voor gezonde vrijwilligers van Japanse komaf voor medewerking ... gevestigde PCRU is één van twee onderzoekseenheden ... ideaal levens te verbeteren door de ontdekking en ontwikkeling ... PCRU op zoek naar mannen en vrouwen van Japanse ...
(Date:7/30/2014)... -- Hologic, Inc. (NASDAQ: HOLX ) today announced ... 28, 2014. Third Quarter Financial Highlights and ... million, reflecting operational growth of 0.5% and a positive ... in the prior year. , Revenues grew in ... revenues grew 3.5%. , GYN Surgical revenues grew ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17
... PITTSBURGH , July 14 D3 Radiation Services announced ... service designed to reduce errors in the delivery of radiation therapy--as a ... , , , ... participating clinics and radiation oncology physicists can order a comprehensive audit of ...
... PITTSBURGH , July 14 Mylan Inc. ... Matrix Laboratories Limited has received final approval from the ... New Drug Application (ANDA) for Nabumetone Tablets USP, 500 ... be bioequivalent and, therefore, therapeutically equivalent to Nabumetone Tablets, ...
Cached Medicine Technology:eDataAudit Receives Approval from the American Board of Radiology 2Mylan Receives Approval for Nabumetone Tablets 2
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The link ribbed hip stem for cementless primary hip replacement surgery....
The uncemented hip joint prosthesis system...
Medicine Products: